Cargando…

Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy

Graves’ disease (GD) is an organ-specific autoimmune disorder of the thyroid, which is characterized by circulating TSH-receptor (TSH-R) stimulating antibodies (TSAb), leading to hyperthyroidism. Graves’ ophthalmopathy (GO) is one of GD extra-thyroidal manifestations associated with the presence of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fallahi, Poupak, Ferrari, Silvia Martina, Elia, Giusy, Ragusa, Francesca, Paparo, Sabrina Rosaria, Patrizio, Armando, Camastra, Stefania, Miccoli, Mario, Cavallini, Gabriella, Benvenga, Salvatore, Antonelli, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085526/ https://www.ncbi.nlm.nih.gov/pubmed/33935970 http://dx.doi.org/10.3389/fendo.2021.654473

Ejemplares similares

Precision Medicine in Graves’ Disease and Ophthalmopathy
por: Elia, Giusy, et al.
Publicado: (2021)

The Synergistic Effect of Corticosteroids and Mycophenolic Acid on Chemokines in Orbital Cells From Patients With Graves’ Ophthalmopathy
por: Fallahi, Poupak, et al.
Publicado: (2021)

FRI530 Immune-Modulation By Rapamycin, Or Mycophenolic Acid, Of Th1 And Th2 Chemokines Secretion In Retro-orbital Cells Of Patients With Graves’ Ophthalmopathy
por: Elia, Giusy, et al.
Publicado: (2023)

Nutraceuticals in Thyroidology: A Review of in Vitro, and in Vivo Animal Studies
por: Benvenga, Salvatore, et al.
Publicado: (2020)

MON-594 Report Of A Large Series Of Patients With Graves' Disease (with/without Graves' Ophthalmopathy) And Review Of The Literature, About The Association With Other Autoimmune Diseases
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine
por: Antonelli, Alessandro, et al.
Publicado: (2021)

Graves’ Disease Following SARS-CoV-2 Vaccination: A Systematic Review
por: Patrizio, Armando, et al.
Publicado: (2022)

Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination
por: Patrizio, Armando, et al.
Publicado: (2022)

Myoinositol in Autoimmune Thyroiditis
por: Paparo, Sabrina Rosaria, et al.
Publicado: (2022)

FRI487 Oral Liquid L- Thyroxine (L-T4) Is More Effective In Controlling Hypothyroidism, Than L-T4 Tablet, In Patients Submitted To Total Thyroidectomy
por: Fallahi, Poupak, et al.
Publicado: (2023)

MON-LB102 Liquid L-Thyroxine Can Maintain Stable TSH Values in Patients with Hypothyroidism: A Prospective Study
por: Fallahi, Poupak, et al.
Publicado: (2019)

Oral Liquid L-Thyroxine (L-T4) May Be Better Absorbed in Comparison to L-T4 Tablets in Patients With Lactose Intolerance
por: Fallahi, Poupak, et al.
Publicado: (2021)

Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism
por: Ferrari, Silvia Martina, et al.
Publicado: (2021)

Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
por: Fallahi, Poupak, et al.
Publicado: (2019)

Chemokines in hyperthyroidism
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

L-T4 Therapy in Enteric Malabsorptive Disorders
por: Fallahi, Poupak, et al.
Publicado: (2021)

Molecular features of aggressive thyroid cancer
por: Elia, Giusy, et al.
Publicado: (2022)

ODP598 Liquid levothyroxine (L-T4) maintains more stable TSH levels in hypothyroid patients, than tablet L-T4
por: Antonelli, Alessandro, et al.
Publicado: (2022)

PSAT366 Liquid L-thyroxine (L-T4) Formulation Normalizes TSH in Hypothyroid Patients Treated with Tablets L-T4
por: Antonelli, Alessandro, et al.
Publicado: (2022)

Thyroid Metastasis from Primary Breast Cancer
por: Patrizio, Armando, et al.
Publicado: (2023)

Thyroid Autoimmunity and SARS-CoV-2 Infection
por: Fallahi, Poupak, et al.
Publicado: (2023)

MON-625 Serum Tsh Levels Normalisation In Patients With Celiac Disease After The Switch From Oral L-t4 In Tablet Form To L-t4 In Liquid Formulation
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

Immune and Inflammatory Cells in Thyroid Cancer Microenvironment
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C?
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series
por: Fallahi, Poupak, et al.
Publicado: (2022)

Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture
por: Ferrari, Silvia Martina, et al.
Publicado: (2023)

Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer
por: Ragusa, Francesca, et al.
Publicado: (2022)

Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases
por: Antonelli, Alessandro, et al.
Publicado: (2021)

Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration
por: Ferrari, Silvia Martina, et al.
Publicado: (2018)

A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination
por: Patrizio, Armando, et al.
Publicado: (2021)

Autoimmune Endocrine Dysfunctions Associated with Cancer Immunotherapies
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

MON-564 Patients Thyroidectomized For Thyroid Cancer (without Malabsorption) In Treatment With L-thyroxine (L-T4) In Soft Gel Capsule Formulation
por: Fallahi, Poupak, et al.
Publicado: (2019)

Oral L‐thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study
por: Fallahi, Poupak, et al.
Publicado: (2018)

MON-566 Early Diagnosis of Lymph Node Metastases by Serum Tg and Neck Ultrasonography, and Long Term Follow Up After Radioiodine and/or Surgical Treatment in Patients with Papillary or Follicular Thyroid Cancer.
por: Fallahi, Poupak, et al.
Publicado: (2019)

Environmental Issues in Thyroid Diseases
por: Ferrari, Silvia Martina, et al.
Publicado: (2017)

Selective use of vandetanib in the treatment of thyroid cancer
por: Fallahi, Poupak, et al.
Publicado: (2015)

Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity
por: Ruffilli, Ilaria, et al.
Publicado: (2017)

New Therapies for Dedifferentiated Papillary Thyroid Cancer
por: Fallahi, Poupak, et al.
Publicado: (2015)

Peroxisome Proliferator-Activated Receptor-γ in Thyroid Autoimmunity
por: Ferrari, Silvia Martina, et al.
Publicado: (2015)

Autophagy in graves’ ophthalmopathy
por: Chen, Yu-Qing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2fqo9ba9putmsgcgrfj19drebt